Biotechnology experts convene in Taiwan to fight the spread of the pandemic
This year, Rieckermann participated for the third time in the Bio Asia Taiwan International Conference and Exhibition, an event that brings together biotechnology and pharmaceutical executives and investors from North America, Europe, and Asia to explore business opportunities in Taiwan’s emerging biotech sector. The theme of the exhibition reflects the cooperation across the entire healthcare industry spectrum in fighting the COVID-19 pandemic.
At their booth, Rieckermann showcased their technology for a laboratory fluidized bed system designed to test granulation, drying, and coating processes, a laboratory leaking inspection machine, as well as tablet printing, laser drilling, and inspection perfection solutions for tablets, capsules, and softgels.
The 2021 Bio Asia Exhibition took place not only physically, but also in a virtual setting with online meeting lounges and other social media-type activities. The new setup aimed to facilitate and replicate a typical conference experience. The Bio Asia Exhibition is an efficient communication platform for Taiwan’s biotechnology industry and aspires to curb the spread of the pandemic. The event, which was originally intended to be held in July 2021, was postponed to November 4 to 7 due to the COVID-19 situation in Taiwan.
Rieckermann first opened their doors in Taiwan in November 2018 with the launch of a liaison office to offer their services to the pharmaceutical industry.